Atlantic Health Strategies

Rhode Island’s OTP Audit Just Handed Every Operator a Preview of the Next Enforcement Wave

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

What the Rhode Island findings actually say, and why operators in every state should read them

Rhode Island’s October 7 performance audit of opioid treatment programs is a leading indicator of state-level enforcement risk, and operators should run an internal audit now against 42 CFR Part 8, state licensure rules, and ASAM Criteria rather than wait for a surveyor to arrive. The Rhode Island Office of the Auditor General reviewed 100 Medicaid claims from all five opioid treatment providers billing the state program during 2023 and 2024, and every single claim had at least one problem. The oversight gap sits with the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), whose inspection cadence of every other year was described in the audit as insufficient to ensure full compliance with mandatory regulatory requirements.

The dollars are not small. The Medicaid program disbursed $875,696 in potential improper payments for Opioid-Use-Disorder treatment services furnished by Opioid Treatment Programs between January 1, 2023 and December 31, 2024. Separately, auditors extrapolated the sample across the full population and estimated that of $25,541,470 Medicaid paid for 274,412 claims, roughly $24,921,184 in services failed to meet all requirements supporting reimbursement. If you operate an OTP anywhere in the country, assume HHS-OIG is watching Rhode Island as a template. The audit was conducted with the Boston office of the U.S. Department of Health and Human Services Office of Inspector General, which is the same office that has already published Medicaid OTP audits in Massachusetts and New Hampshire.

The deficiency categories, mapped to the federal citation and the fix

Pull quote: 95 of 100 sampled cases had deficiencies in required patient assessments.

Pull the Rhode Island report apart and the deficiency pattern is familiar to anyone who has sat through a SAMHSA inspection or a CARF OTP survey. Of the 100 sampled cases, 95 had deficiencies involving required patient assessments, 75 had problems with treatment plan reviews, and 70 failed counseling requirements. In 29 cases, patients had no documented counseling during at least one calendar year. Auditors counted 1,729 deficiencies. On top of that, the deficiencies involved inadequate or missing documentation, such as patients’ biopsychosocial assessments, treatment plans, counseling services, toxicology screenings, medical examinations and care coordination.

Here is the operator-side map:

  • Biopsychosocial assessments missing or stale: This is a 42 CFR Part 8 and state licensure finding, and it is also where payers will deny on medical necessity. The audit explicitly warns that missing or poorly documented biopsychosocial assessments undermine the provider’s ability to determine appropriate treatment needs, evaluate medical necessity and ensure safe, effective and individualized care. Fix: a quarterly chart audit against ASAM Criteria 4th Edition dimensional assessment elements, with a corrective action plan tied to each missing field.
  • Treatment plans not updated or individualized: This is the single most common finding in OTP surveys nationally, and it is a direct recoupment risk. Fix: a documentation standard that requires every plan review to show patient voice, measurable goals, and the clinical rationale for continued stay at the current level of care.
  • Counseling hours not met or not documented: This is also the finding that most closely mirrors prior OIG work. OIG’s New Hampshire OTP audit specifically reviewed whether counseling hour and toxicology testing requirements were met, initial treatment plans were prepared, treatment plans were reviewed as required, and the OTP service was provided. If RI’s pattern looks like NH’s, OIG already knows the playbook.
  • Daily methadone billed instead of the weekly bundle: The state’s Medicaid plan establishes a weekly bundled payment methodology for opioid treatment services, under which providers must submit a single claim, and providers in RI billed daily methadone treatments when Medicaid required one bundled weekly claim, with some patients generating five to seven paid claims in a week. Fix: a billing-side edit in the EMR that blocks daily codes for bundled services, plus a monthly reconciliation between dosing logs and claims.

The 2024 revisions to 42 CFR Part 8 raised the documentation stakes, not lowered them

Operators who read the 2024 revisions to 42 CFR Part 8 as a loosening need to re-read them. On February 1, 2024, SAMHSA issued a final rule revising 42 CFR Part 8, which regulates opioid treatment programs, representing the first update to the OTP regulations in over 20 years and significantly increasing access to lifesaving medication while easing operational restrictions. The rules went into effect on April 2, 2024 and the compliance date was October 2, 2024.

The flexibilities are real. The final rule updates criteria for consideration of take-home doses of methadone and allows patients to receive take-home doses from the first week of treatment under certain conditions, and safeguards like diversion control procedures remain. But the clinical judgment now sits squarely with the practitioner, and SAMHSA has added patient-provider shared decision making considerations to all care plans and incorporated harm reduction principles into treatment. That means the chart has to show the shared decision. It has to show the diversion risk assessment. It has to show why this patient qualifies for a first-week take-home. If your clinicians are using the new flexibilities but your documentation still looks like a 2019 methadone chart, you are building a recoupment case against yourself.

As SAMHSA’s Dr. Yngvild Olsen put it in the agency’s implementation series, “These historic changes recognize the significant role OTPs play in the specialty behavioral health care system.” The flip side of that recognition is scrutiny. The DEA Diversion Control Division is still watching take-home patterns, and the State Opioid Treatment Authority (SOTA) in your state still has to approve exceptions.

What a defensible internal audit actually looks like

The question I get from OTP operators the week after a story like Rhode Island breaks is always the same: what should we actually do by Friday. Here is the short version.

  1. Pull a stratified sample of 30 to 50 active charts across admission, stable, and tapering patients. Score each chart against the exact Part 8 element list and your state licensure checklist. Not vibes. A line-item checklist with a yes, no, or N/A for every requirement.
  2. Reconcile the dosing log to the claims file for a 90-day window. Look for daily codes where a bundle was required, missed dose days still billed, and discharge weeks billed as full weeks. This is where the RI overpayment number came from, and it is the easiest finding for an auditor to extrapolate.
  3. Run a counseling-hours report by payer. ASAM Criteria 4th Edition, state Medicaid, and commercial payer definitions do not always agree on what counts as a counseling encounter. If your team is documenting a group as individual, or counting a brief medication check as counseling, you have a problem that compounds across every patient.
  4. Build the corrective action plan before you need it. Auditors do not expect perfection. They expect proof that you identify issues and fix them. The CAP template should name the finding, the root cause, the owner, the deadline, and the monitoring evidence.
  5. Document medical necessity to the standard, not the summary. If your notes do not clearly justify continued stay at the OTP level of care under ASAM, the authorization is not a shield. Payers will take the money back later. We see it on nearly every operational audit we run.

One honest note from the Rhode Island reporting. Linda Hurley, CODAC’s president and CEO, did not deny that regulatory noncompliance has occurred at her facilities, but she disputed the audit’s interpretations of its findings, saying “They’re not awful, but there are certain things that certainly need to be modernized.” That tension, between what clinicians believe is good care and what the regulations require on paper, is where almost every OTP operator lives. The chart has to carry the clinical story in a form a surveyor can score. If it does not, the clinical story does not count.

Pull quote: The chart has to carry the clinical story in a form a surveyor can score.

Frequently asked questions

What specific compliance failures did the Rhode Island auditors identify in opioid treatment programs?
The Rhode Island Office of the Auditor General found that every one of 100 sampled Medicaid claims across all five OTPs billing the state in 2023 and 2024 had at least one state or federal problem. Of those, 95 had deficiencies in required patient assessments, 75 had treatment plan review problems, and 70 failed counseling requirements. The audit also flagged $875,696 in potential overpayments tied to providers billing daily methadone treatments when the state Medicaid plan requires a single weekly bundled claim.

How do the 2024 revisions to 42 CFR Part 8 change OTP documentation and take-home dosing requirements?
The revised rule, effective April 2, 2024 with a compliance date of October 2, 2024, permanently codified pandemic-era flexibilities. It updates criteria for consideration of take-home methadone and allows take-homes from the first week of treatment under certain conditions, and medication access is no longer contingent on receipt of counseling. Operators must document the practitioner’s clinical judgment, the diversion risk assessment, and the shared decision-making conversation for every take-home decision.

What should an OTP operator include in a corrective action plan after a state or SAMHSA citation?
Name the finding, state the root cause (training, workflow, EMR, policy, or oversight), assign a single owner, set a deadline, and define the monitoring evidence that proves the fix held. Tie each item back to the specific regulatory citation, whether 42 CFR Part 8, state licensure rule, CARF or Joint Commission standard, or payer manual language.

How often should OTPs conduct internal mock audits against SAMHSA, DEA, and accreditation standards?
Quarterly chart audits at minimum, with a full operational audit annually that covers dosing, diversion control, counseling delivery, billing reconciliation, and medical necessity documentation. States that inspect every other year, as BHDDH does in Rhode Island, are not catching problems in real time. The internal cadence has to.

Which Rhode Island findings are most likely to trigger payer recoupment or OIG scrutiny?
The daily-versus-bundled methadone billing pattern is the fastest recoupment path, because the dollars are quantifiable from a claims pull. Missing or stale biopsychosocial assessments and undocumented counseling are the strongest medical necessity denials. And because the RI audit was conducted jointly with the HHS-OIG Boston office, assume these categories are already in the OIG workplan for other states.

Request a Free Consultation

Scroll to Top